NCT00259740
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT00577642
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00600353
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States
NCT00143845
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
- Locations
-
- The University of Michigan Ann Arbor, Michigan, United States
NCT00755040
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Norwestern Memorial Hospital Chicago, Illinois, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- M. D. Anderson Cancer Center Houston, Texas, United States
NCT00408681
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adnexal Diseases, Adult Acute Lymphoblastic Leukemia in Remission, +221 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00307086
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
Completed
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
NCT00434447
- Conditions
- Blood Protein Disorders, Bone Diseases, Bone Neoplasms, +33 more
- Locations
-
- Novartis Investigative Site Canberra, Australian Capital Territory, Australia
- Novartis Investigative Site Concord, New South Wales, Australia
- Novartis Investigative Site Liverpool, New South Wales, Australia
- Novartis Investigative Site Wagga Wagga, New South Wales, Australia
NCT00523848
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT02401295
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States